® disp is used as the core drug. smc with spaq-co® disp effectively reduced the morbidity of malaria in children under five years old in africa.
with advantage of its product advantages, fosun pharma has organized 11 seminars on malaria prevention and control in developing countries, 6 seminars on quality management in developing countries, and 4 ministerial seminars on drug regulation in developing countries, in which more than 50 countries have participated.
  • fight against covid-19 pandemic

    fight against covid-19 pandemic

    since the outbreak of the covid-19 pandemic in 2020, fosun pharma has made full use of its innovation capabilities and international experiences to actively participate in the global fight against the epidemic, with mobilization of supplies from around the world, development of covid-19 drugs and research and development of novel coronavirus nucleic acid and antigen detection reagents. in collaboration with germany's biontech to jointly develop mrna covid-19 vaccine, fosun pharma continues to help fight the covid-19 pandemic.
    comirnaty® (mrna covid-19 vaccine) jointly developed by fosun pharma and biontech, was included in the government vaccination programs in hong kong sar and macau sar in march 2021 and supplied to the taiwan region in september 2021. by the end of february 2022, over 20 million doses of bnt162b2 have been administrated in hong kong sar, macau sar, and taiwan region, helping to establish the local covid-19 immune barrier. sublicensed from mpp to manufacture both drug substance and product and commercialize covid-19 oral drugs molnupiravir and paxlovid in agreed low- and middle-income countries.

  • han da yuan® patient caring program

    han da yuan® patient caring program

    to help treat more patients with autoimmune diseases, fosun pharma has established the first whole-process care platform in china for them, called "dagen's home", which incorporates internet hospitals, science popularization education, public welfare assistance, medical insurance, patient management, medicine purchase map, and community care. by the end of 2021, "dagen's home" had provided 1v1 special services for over 5,000 patients in total, solving their problems in consultation, diagnosis, treatment, and prognosis. besides, it donated mr. li hua, who suffered from ankylosing spondylitis (as), all the han da yuan® that he would need.

  • more stories
    • 2,271 million
      tax payment
    • 4,975 million
      r&d expenditure for 2021 (including capitalized expenditures)
    • 36,279
      global job creation
    • 36.06 million
      public welfare donations in 2021
    • 14 years
      published corporate social responsibility report for
    • 48.00 million
      severe malaria patients treated with artesunate
    *data from: fosun pharma 2021 corporate social responsibility report